Article
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody.
Frontiers in immunology - 1 Jan 2021
Yue Shuai, Li Zhirong, Lin Yao, Yang Yang, Yuan Mengqi, Pan Zhiwei, Hu Li, Gao Leiqiong, Zhou Jing, Tang Jianfang, Wang Yifei, Tian Qin, Hao Yaxing, Wang Juan, Huang Qizhao, Xu Lifan, Zhu Bo, Liu Pinghuang, Deng Kai, Wang Li, Ye Lilin, Chen Xiangyu
Abstract excerpt
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of novel coronavirus disease (COVID-19). Though vaccines and neutralizing monoclonal antibodies (mAbs) have been developed to fight COVID-19 in the past year, one major concern is the emergence of SARS-CoV-2 variants of concern (VOCs). Indeed, SARS-CoV-2 VOCs such as B.1.1.7 (UK), B.1.351 (South Africa), P.1 (Brazil),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.